Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age

<p><strong>Background</strong>: Hepatitis B (HB) infections are a global public health concern, which carry high morbidity and mortality. Immunization is the safe and effective intervention to prevent transmission. Currently, the Hepatitis B vaccine is given to children at two, fou...

Full description

Bibliographic Details
Main Authors: PJ Perera, MD Fernando, M Hapugoda, L Udayanga
Format: Article
Language:English
Published: Sri Lankan Society for Microbiology 2022-02-01
Series:Sri Lankan Journal of Infectious Diseases
Subjects:
Online Access:https://sljid.sljol.info/articles/8419
_version_ 1797985095564394496
author PJ Perera
MD Fernando
M Hapugoda
L Udayanga
author_facet PJ Perera
MD Fernando
M Hapugoda
L Udayanga
author_sort PJ Perera
collection DOAJ
description <p><strong>Background</strong>: Hepatitis B (HB) infections are a global public health concern, which carry high morbidity and mortality. Immunization is the safe and effective intervention to prevent transmission. Currently, the Hepatitis B vaccine is given to children at two, four and six months of age in Sri Lanka. However, the capability of this regimen in providing long term protection up to adolescence and beyond remains a concern. The current study was conducted to assess the HB immune status of children, ten years after vaccination during infancy.</p><p><strong> </strong></p><p><strong>Methods: </strong>Antibody status of 150 children who received HB vaccine at two, four and six months of age was assessed 10 years after the last dose of vaccination. Some of these children had received liquid monovalent HB vaccine, while others were vaccinated with the Hexavalent vaccine. Children with HB antibody levels below the protective level were given a booster dose of monovalent recombinant HB vaccine, and antibody levels were reassessed in one month.</p><p><strong> </strong></p><p><strong>Results: </strong>At the initial assessment, 128 children (85%) had protective levels of antibodies. Type of vaccine and gender had no significant effect on the prevalence of HB antibody levels (p&gt;0.05). All children who received the booster dose developed protective levels of antibodies.</p><p><strong> </strong></p><p><strong>Conclusions: </strong>Most of the children immunized against HB during infancy maintain protective antibody levels at 10 years of age. Children with antibody levels below protective levels produced a rapid anamnestic response following a booster dose.</p><p>.</p>
first_indexed 2024-04-11T07:13:13Z
format Article
id doaj.art-5340a1e546414c9cb0f0efb5201ecf31
institution Directory Open Access Journal
issn 2012-8169
2448-9654
language English
last_indexed 2024-04-11T07:13:13Z
publishDate 2022-02-01
publisher Sri Lankan Society for Microbiology
record_format Article
series Sri Lankan Journal of Infectious Diseases
spelling doaj.art-5340a1e546414c9cb0f0efb5201ecf312022-12-22T04:38:06ZengSri Lankan Society for MicrobiologySri Lankan Journal of Infectious Diseases2012-81692448-96542022-02-011211810.4038/sljid.v12i1.84195946Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of agePJ Perera0MD Fernando1M Hapugoda2L Udayanga3Faculty of Medicine, University of KelaniyaFaculty of Medicine, University of KelaniyaFaculty of Medicine, University of KelaniyaFaculty of Medicine, University of Kelaniya<p><strong>Background</strong>: Hepatitis B (HB) infections are a global public health concern, which carry high morbidity and mortality. Immunization is the safe and effective intervention to prevent transmission. Currently, the Hepatitis B vaccine is given to children at two, four and six months of age in Sri Lanka. However, the capability of this regimen in providing long term protection up to adolescence and beyond remains a concern. The current study was conducted to assess the HB immune status of children, ten years after vaccination during infancy.</p><p><strong> </strong></p><p><strong>Methods: </strong>Antibody status of 150 children who received HB vaccine at two, four and six months of age was assessed 10 years after the last dose of vaccination. Some of these children had received liquid monovalent HB vaccine, while others were vaccinated with the Hexavalent vaccine. Children with HB antibody levels below the protective level were given a booster dose of monovalent recombinant HB vaccine, and antibody levels were reassessed in one month.</p><p><strong> </strong></p><p><strong>Results: </strong>At the initial assessment, 128 children (85%) had protective levels of antibodies. Type of vaccine and gender had no significant effect on the prevalence of HB antibody levels (p&gt;0.05). All children who received the booster dose developed protective levels of antibodies.</p><p><strong> </strong></p><p><strong>Conclusions: </strong>Most of the children immunized against HB during infancy maintain protective antibody levels at 10 years of age. Children with antibody levels below protective levels produced a rapid anamnestic response following a booster dose.</p><p>.</p>https://sljid.sljol.info/articles/8419hepatitis b, immunity, immunization, antibodies
spellingShingle PJ Perera
MD Fernando
M Hapugoda
L Udayanga
Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
Sri Lankan Journal of Infectious Diseases
hepatitis b, immunity, immunization, antibodies
title Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
title_full Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
title_fullStr Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
title_full_unstemmed Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
title_short Immunity against hepatitis B in a selected child population in Gampaha district, Sri Lanka, ten years after vaccination at two, four and six months of age
title_sort immunity against hepatitis b in a selected child population in gampaha district sri lanka ten years after vaccination at two four and six months of age
topic hepatitis b, immunity, immunization, antibodies
url https://sljid.sljol.info/articles/8419
work_keys_str_mv AT pjperera immunityagainsthepatitisbinaselectedchildpopulationingampahadistrictsrilankatenyearsaftervaccinationattwofourandsixmonthsofage
AT mdfernando immunityagainsthepatitisbinaselectedchildpopulationingampahadistrictsrilankatenyearsaftervaccinationattwofourandsixmonthsofage
AT mhapugoda immunityagainsthepatitisbinaselectedchildpopulationingampahadistrictsrilankatenyearsaftervaccinationattwofourandsixmonthsofage
AT ludayanga immunityagainsthepatitisbinaselectedchildpopulationingampahadistrictsrilankatenyearsaftervaccinationattwofourandsixmonthsofage